BioCentury
ARTICLE | Company News

BioRelix, University of Colorado deal

October 20, 2008 7:00 AM UTC

The university granted BioRelix an exclusive, worldwide license to IP covering undisclosed riboswitch technology. According to the university, BioRelix has a previous license to another riboswitch tec...